Semaglutide (Rybelsus®): clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Semaglutide (Rybelsus®)

• Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
  NCT07401992 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
  NCT07221214 · Phase: Phase 2 · Ages: 18 Years to 89 Years · Sex: All (male and female) · 1 location
• GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
  NCT06338553 · Phase: Early Phase 1 · Ages: 12 Years to 50 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Semaglutide (Rybelsus®)?

3 recruiting trials across 11 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.